Company / Revenue
Beta Bionics, Inc. Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$100.3M
FY2025
5-year range
$12.0M / $100.3M
FY2023-FY2025
Trend
+53.9%
vs FY2024
Sector context
#147 of 156
Health Care
What the data says
Among 156 Health Care companies, Beta Bionics, Inc. is in the bottom 6% for revenue. Improved from $12M to $100M over the past 2 years.
Based on SEC 10-K filings.
$100M in FY2025.
Improved from $12M to $100M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 156This company $100.3M Sector average $19.0B
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 53.9% year-over-year.
- Ranks #147 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.3M | +53.9% |
| FY2024 | $65.1M | +442.9% |
| FY2023 | $12.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026